Study to Obtain Blood and Voided Urine Samples to Improve the Diagnosis of Melioidosis
Establishment of a Reference Clinical Sample Panel Allowing for the Development and Proof-of-concept Validation of an In-vitro Diagnostic Test for the Diagnosis of Melioidosis
Sponsor: Institute of Tropical Medicine, Belgium
Listed as NCT02668406, this observational or N/A phase trial focuses on Melioidosis and Suspected or Confirmed Bloodstream Infections and remains completed. Sponsored by Institute of Tropical Medicine, Belgium, it has been updated 14 times since 2016, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 9 earlier versions
-
Nov 2018 — Nov 2020 [monthly]
Completed
Status: Recruiting → Completed
-
Sep 2018 — Nov 2018 [monthly]
Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jul 2017 — Aug 2017 [monthly]
Recruiting NA
-
Feb 2017 — Jul 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Feb 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Institute of Tropical Medicine, Belgium
- SRI International
- Sihanouk Hospital Center of HOPE
For direct contact, visit the study record on ClinicalTrials.gov .